Biotech | June 15, 2022
ProBioGen and ValenzaBio enter second service agreement
The new program includes upstream and downstream process development and large-scale GMP production.
The new program includes upstream and downstream process development and large-scale GMP production.
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Alopecia areata usually presents as a few small bald patches in the head
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Acceptance based on results from the phase 3 KEYNOTE-091 trial
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America
Subscribe To Our Newsletter & Stay Updated
